United States · 
Who invested in Switch Therapeutics?
Switch Therapeutics's investors include Insight Partners, CRV, Global Brain Corporation, Upfront Ventures and Digitalis Ventures.
United States · Series A startup
Who invested in Switch Therapeutics
Funding summaryUpdated 26 Oct 2026
$52Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $52MMar 2023
- Investors
- 5
The rounds
- Mar 2023Series A$52M
Source recordedSEC filing: $23M sold, first sale Sept 2022
Founders and team
From the SEC filings it signed: 2 on the team.
- Deepshikha DattaChief Executive Officer and Presidenti
- Si-Ping HanSecretaryi
On the board, as filediAlicia Irurzun-LafitteDylan MorrisKevin Zhang
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Switch Therapeutics
How much has Switch Therapeutics raised?
Switch Therapeutics has raised $52M across 1 round since 2023.
When did Switch Therapeutics last raise?
Switch Therapeutics's most recent round was a Series A of $52M in Mar 2023.
What was Switch Therapeutics's biggest round?
Its most recent round, $52M in Mar 2023, is also its largest on record.
Who backed Switch Therapeutics first?
Switch Therapeutics's first round on record, in Mar 2023, was backed by Insight Partners, CRV and Global Brain Corporation and 2 others.
What stage is Switch Therapeutics at?
Switch Therapeutics's latest named round is a Series A, in Mar 2023.
Where is Switch Therapeutics based?
Switch Therapeutics is based in the United States.
Companies like Switch Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.